OKTA vs TWST · P/E 84, rev $1.57B vs rev $332.8M
Okta Inc (OKTA) versus Twist Bioscience Corp (TWST) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. TWST currently screens at market cap $5.16B.
Not investment advice. Open the OKTA and TWST stock pages for the full models.
Not investment advice.